Clinical Trials
20 trialsNCT04300998 2026-04-07
Study of CAR-T Therapy in Older Patients
Memorial Sloan Kettering Cancer Center
Recruiting
NCT07342179 2026-02-18
CART I5M
Poitiers University Hospital
Phase NA Recruiting
NCT06644625 2026-01-20
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
Wake Forest University Health Sciences
Recruiting
NCT02800954 2025-11-19
MCSF-MYELOME
Centre Hospitalier Universitaire, Amiens
Phase NA Completed
NCT04111809 2025-09-25
AMBROBiMM
Assistance Publique - Hôpitaux de Paris
Terminated
NCT06474182 2025-09-25
ProApix
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Recruiting
NCT05259553 2025-04-09
VESICOM
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Recruiting
NCT05735704 2025-03-26
SANGUINE
JaxBio Ltd
Unknown
NCT03804424 2024-11-12
64Cu-LLP2A for Imaging Multiple Myeloma
Washington University School of Medicine
Phase EARLY_PHASE1 Terminated
NCT03508765 2024-03-08
Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT05428163 2023-11-08
MYELOME-MM
Assistance Publique Hopitaux De Marseille
Completed
NCT04872023 2023-02-03
IMMUNO-MYELO
Rennes University Hospital
Phase NA Completed
NCT02627261 2022-09-06
MMRD
Hospices Civils de Lyon
Completed
NCT04150692 2022-01-24
Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma
Washington University School of Medicine
Phase 2 Withdrawn
NCT03956615 2021-12-01
MUM
Universitair Ziekenhuis Brussel
Phase NA Completed
NCT03665155 2021-07-30
First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT00569309 2018-03-12
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT01472627 2018-01-11
Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro
Dana-Farber Cancer Institute
Completed
NCT02260414 2017-05-11
METRO B
Centre Hospitalier Universitaire de Saint Etienne
Phase 2 Completed
NCT00639054 2016-01-07
MM-FISH/DNA
Rigshospitalet, Denmark
Completed